204. Di Carli MF, Dorbala S, Curillova Z, et al. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol. 2007;14:799 809. 205. Pazhenkottil AP, Husmann L, Kaufmann PA. Cardiac hybrid imaging with high-speed single-photon emission computed tomography/CT camera to detect ischaemia and coronary artery obstruction. Heart. 2010;96:2050. 206. Pazhenkottil AP, Nkoulou RN, Ghadri J-R, et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J. 2011;32:1465 71. 207. van Velzen JE, Schuijf JD, van Werkhoven JM, et al. Predictive value of multislice computed tomography variables of atherosclerosis for ischemia on stress-rest single-photon emission computed tomography. Circ Cardiovasc Imaging. 2010;3:718 26. 208. Min JK, Shaw LJ, Berman DS. The present state of coronary computed tomography angiography a process in evolution. J Am Coll Cardiol. 2010;55:957 65. 209. Mark DB, Berman DS, Budoff MJ, et al. ACCF/ACR/AHA/NASCI/ SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Doc- uments. Circulation. 2010;121:2509 43. 210. Pundziute G, Schuijf JD, Jukema JW, et al. Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart. 2008;94:48 52. 211. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54: 49 57. 212. Shaw LJ, Min JK, Narula J, et al. Sex differences in mortality asso- ciated with computed tomographic angiographic measurements of obstructive and nonobstructive coronary artery disease: an exploratory analysis. Circ Cardiovasc Imaging. 2010;3:473 81. 213. Motoyama S, Kondo T, Sarai M, et al.


2010;3:473 81. 213. Motoyama S, Kondo T, Sarai M, et al. Multislice computed tomo- graphic characteristics of coronary lesions in acute coronary syn- dromes. J Am Coll Cardiol. 2007;50:319 26. 214. Villines TC, Hulten EA, Shaw LJ, et al. Prevalence and Severity of Coronary Artery Disease and Adverse Events Among Symptomatic Patients With Coronary Artery Calcification Scores of Zero Undergoing Coronary Computed Tomography Angiography: Results From the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) Registry. J Am Coll Cardiol. 2011;58:2540. 215. Shmilovich H, Cheng VY, Tamarappoo BK, et al. Vulnerable plaque features on coronary CT angiography as markers of inducible regional myocardial hypoperfusion from severe coronary artery stenoses. Ath- erosclerosis. 2011;219:588 95. 216. Lin FY, Shaw LJ, Dunning AM, et al. Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography. J Am Coll Cardiol. 2011;58: 510 9. 217. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827 32. 218. O Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol. 2000;32: 326 40. 219. Akram K, O Donnell RE, King S, et al. Influence of symptomatic status on the prevalence of obstructive coronary artery disease in patients with zero calcium score. Atherosclerosis. 2009;203:533 7. 220. Cademartiri F, Maffei E, Palumbo A, et al. Diagnostic accuracy of computed tomography coronary angiography in patients with a zero calcium score. Eur Radiol. 2010;20:81 7. 221. Haberl R, Tittus J, Bohme E, et al.


2010;20:81 7. 221. Haberl R, Tittus J, Bohme E, et al. Multislice spiral computed tomo- graphic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography? Am Heart J. 2005;149:1112 9. 222. Henneman MM, Schuijf JD, Pundziute G, et al. Noninvasive eval- uation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol. 2008; 52:216 22. 223. Rubinshtein R, Gaspar T, Halon DA, et al. Prevalence and extent of obstructive coronary artery disease in patients with zero or low calcium score undergoing 64-slice cardiac multidetector computed tomography for evaluation of a chest pain syndrome. Am J Cardiol. 2007;99:472 5. 224. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004;25:1940 65. 225. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001;345:1863 9. 226. Danias PG, Roussakis A, Ioannidis JP. Diagnostic performance of coronary magnetic resonance angiography as compared against con- ventional X-ray angiography: a meta-analysis. J Am Coll Cardiol. 2004;44:1867 76. 227. Sakuma H. Coronary CT versus MR angiography: the role of MR angiography. Radiology. 2011;258:340 9. 228. Hamdan A, Asbach P, Wellnhofer E, et al. A prospective study for comparison of MR and CT imaging for detection of coronary artery stenosis. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:50 61. 229. Buckley BS, Simpson CR, McLernon DJ, et al. Five year prognosis in patients with angina identified in primary care: incident cohort study. BMJ. 2009;339:b3058. 230. Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298:765 75. 231. Weiner DE, Tighiouart H, Stark PC, et al.


2007;298:765 75. 231. Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198 206. 232. Sachdev M, Sun JL, Tsiatis AA, et al. The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol. 2004;43:576 82. 233. Hlatky MA. Comorbidity and outcome in patients with coronary artery disease. J Am Coll Cardiol. 2004;43:583 4. 234. Chirinos JA, Veerani A, Zambrano JP, et al. Evaluation of comorbidity scores to predict all-cause mortality in patients with established coronary artery disease. Int J Cardiol. 2007;117:97 102. 235. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192 217. 236. Denollet J, Pedersen SS, Vrints CJ, et al. Usefulness of type D per- sonality in predicting five-year cardiac events above and beyond con- current symptoms of stress in patients with coronary heart disease. Am J Cardiol. 2006;97:970 3. 237. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289: 3106 16. 238. Glassman AH, O Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701 9. 239. Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003; 290:215 21. 240. Rumsfeld JS, Magid DJ, Plomondon ME, et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J. 2003;145:493 9. 241. Rumsfeld JS, Jones PG, Whooley MA, et al.


2003;145:493 9. 241. Rumsfeld JS, Jones PG, Whooley MA, et al. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J. 2005;150:961 7. 242. Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation. 2005;111:250 3. 243. Rutledge T, Reis SE, Olson M, et al. Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women s Ischemia Syndrome Evaluation study. Psychosom Med. 2004;66:882 8. 244. Horne BD, Muhlestein JB, Lappe DL, et al. Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease. Ann Epidemiol. 2004;14:143 50. 245. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case- control study. Lancet. 2004;364:953 62. 246. Spertus JA, Jones P, McDonell M, et al. Health status predicts long-term outcome in outpatients with coronary disease. Circulation. 2002;106:43 9. 247. Mozaffarian D, Bryson CL, Spertus JA, et al. Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease. Am Heart J. 2003;146:1015 22. 248. Lauer MS, Pothier CE, Magid DJ, et al. An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electro- cardiogram. Ann Intern Med. 2007;147:821 8. 249. Hubbard BL, Gibbons RJ, Lapeyre AC III, et al. Identification of severe coronary artery disease using simple clinical parameters. Arch Intern Med. 1992;152:309 12. 250. Ho K-T, Miller TD, Hodge DO, et al.


1992;152:309 12. 250. Ho K-T, Miller TD, Hodge DO, et al. Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease. Mayo Clin Proc. 2002;77:515 21. 251. Miller TD, Roger VL, Hodge DO, et al. A simple clinical score accurately predicts outcome in a community-based population undergoing stress testing. Am J Med. 2005;118:866 72. 252. Diamond GA, Kaul S. COURAGE under fire: on the management of stable coronary disease. J Am Coll Cardiol. 2007;50:1604 9. 253. Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: a systematic review and metaanalyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151: 483 95. 254. Oremus M, Raina PS, Santaguida P, et al. A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem. 2008;41:260 5. 255. Shah T, Casas JP, Cooper JA, et al. Critical appraisal of CRP mea- surement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol. 2009;38:217 31. 256. Heslop CL, Frohlich JJ, Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascu- lar mortality after coronary angiography. J Am Coll Cardiol. 2010;55: 1102 9. 257. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735 52. 258. O Donoghue M, Morrow DA, Sabatine MS, et al. Lipoproteinasso- ciated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation. 2006;113:1745 52. 259.


Lipoproteinasso- ciated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation. 2006;113:1745 52. 259. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation. 2006;113:1071 8. 260. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circu- lation. 1982;66:562 8. 261. Vitarelli A, Tiukinhoy S, Di Luzio S, et al. The role of echocardiog- raphy in the diagnosis and management of heart failure. Heart Fail Rev. 2003;8:181 9. 262. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Fra- mingham Heart Study. Ann Intern Med. 1989;110:101 7. 263. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Fra- mingham Heart Study. N Engl J Med. 1990;322:1561 6. 264. Nagao T, Chikamori T, Hida S, et al. Quantitative gated singlephoton emission computed tomography with (99m)Tc sestamibi predicts major cardiac events in elderly patients with known or suspected coronary artery disease: the QGS-Prognostic Value in the Elderly (Q-PROVE) Study. Circ J. 2007;71:1029 34. 265. Leischik R, Dworrak B, Littwitz H, et al. Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longi- tudinal study). Int J Cardiol. 2007;119:297 305. 266. Johansen A, Hoilund-Carlsen PF, Vach W, et al. Prognostic value of myocardial perfusion imaging in patients with known or suspected stable angina pectoris: evaluation in a setting in which myocardial perfusion imaging did not influence the choice of treatment. Clin Physiol Funct Imaging. 2006;26:288 95. 267.


Prognostic value of myocardial perfusion imaging in patients with known or suspected stable angina pectoris: evaluation in a setting in which myocardial perfusion imaging did not influence the choice of treatment. Clin Physiol Funct Imaging. 2006;26:288 95. 267. Badran HM, Elnoamany MF, Seteha M. Tissue velocity imaging with dobutamine stress echocardiography a quantitative technique for identification of coronary artery disease in patients with left bundle branch block. J Am Soc Echocardiogr. 2007;20:820 31. 268. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945 53. 269. Epstein FH. MRI of left ventricular function. J Nucl Cardiol. 2007;14: 729 44. 270. Wagdy HM, Hodge D, Christian TF, et al. Prognostic value of vaso- dilator myocardial perfusion imaging in patients with left bundle- branch block. Circulation. 1998;97:1563 70. 271. Bouzas-Mosquera A, Peteiro J, Alvarez-Garcia N, et al. Prediction of mortality and major cardiac events by exercise echocardiography in patients with normal exercise electrocardiographic testing. J Am Coll Cardiol. 2009;53:1981 90. 272. Navare SM, Mather JF, Shaw LJ, et al. Comparison of risk stratifi- cation with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2004;11:551 61. 273. Gebker R, Jahnke C, Manka R, et al. The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease. J Car- diovasc Magn Reson. 2011;13:46. 274. Peteiro J, Bouzas-Mosquera A, Broullon FJ, et al. Prognostic value of peak and post-exercise treadmill exercise echocardiography in patients with known or suspected coronary artery disease. Eur Heart J. 2010; 31:187 95. 275. Yao SS, Wever-Pinzon O, Zhang X, et al. Prognostic value of stress echocardiogram in patients with angiographically significant coronary artery disease. Am J Cardiol.


Prognostic value of stress echocardiogram in patients with angiographically significant coronary artery disease. Am J Cardiol. 2012;109:153 8. 276. Shaw L, Cerqueira M, Brooks M, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocaridal perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascuarization Investigation 2 Diabetes (BARI 2D) Trial. J Nucl Cardiol. 2012. 277. Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revasculariza- tion vs. medical therapy among patients undergoing stress-rest myo- cardial perfusion scintigraphy. Eur Heart J. 2011;32:1012 24. 278. Doesch C, Seeger A, Doering J, et al. Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:424 33. Fihn et al Stable Ischemic Heart Disease: Full Text e441 279. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobu- tamine stress wall motion imaging. Circulation. 2007;115:1769 76. 280. Bingham SE, Hachamovitch R. Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress per- fusion, delayed enhancement, and left ventricular function over pre- imaging information for the prediction of adverse events. Circulation. 2011;123:1509 18. 281. Coelho-Filho OR, Seabra LF, Mongeon F-P. Stress Myocardial Per- fusion Imaging by CMR Provides Strong Prognostic Value to Cardiac Events Regardless of Patient s Sex. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:850 61. 282. Kelle S, Chiribiri A, Vierecke J, et al. Long-term prognostic value of dobutamine stress CMR. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:161 72. 283. Korosoglou G, Elhmidi Y, Steen H, et al.


2011;4:161 72. 283. Korosoglou G, Elhmidi Y, Steen H, et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol. 2010;56:1225 34. 284. Steel K, Broderick R, Gandla V, et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation. 2009;120:1390 400. 285. Chow BJW, Wells GA, Chen L, et al. Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction. J Am Coll Cardiol. 2010;55:1017 28. 286. Min JK, Dunning A, Lin FY, et al. Age- and Sex-Related Differences in All-Cause Mortality Risk Based on Coronary Computed Tomography Angiography Findings Results From the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23 854 Patients Without Known Coronary Artery Disease. J Am Coll Cardiol. 2011;58:849 60. 287. America YGCJ, Bax JJ, Boersma E, et al. Prognostic value of gated SPECT in patients with left bundle branch block. J Nucl Cardiol. 2007;14:75 81. 288. Gil VM, Almeida M, Ventosa A, et al. Prognosis in patients with left bundle branch block and normal dipyridamole thallium-201 scintigra- phy. J Nucl Cardiol. 1998;5:414 7. 289. Nallamothu N, Bagheri B, Acio ER, et al. Prognostic value of stress myocardial perfusion single photon emission computed tomography imaging in patients with left ventricular bundle branch block. J Nucl Cardiol. 1997;4:487 93. 290. Nigam A, Humen DP. Prognostic value of myocardial perfusion imaging with exercise and/or dipyridamole hyperemia in patients with preexisting left bundle branch block. J Nucl Med. 1998;39:579 81. 291. Pilz G, Jeske A, Klos M, et al. Prognostic value of normal adenosine- stress cardiac magnetic resonance imaging.


Prognostic value of normal adenosine- stress cardiac magnetic resonance imaging. Am J Cardiol. 2008;101: 1408 12. 292. Tandogan I, Yetkin E, Yanik A, et al. Comparison of thallium-201 exercise SPECT and dobutamine stress echocardiography for diagnosis of coronary artery disease in patients with left bundle branch block. Int J Cardiovasc Imaging. 2001;17:339 45. 293. Hacker M, Jakobs T, Hack N, et al. Combined use of 64-slice computed tomography angiography and gated myocardial perfusion SPECT for the detection of functionally relevant coronary artery ste- noses. First results in a clinical setting concerning patients with stable angina. Nuklearmedizin. 2007;46:29 35. 294. Yao SS, Bangalore S, Chaudhry FA. Prognostic implications of stress echocardiography and impact on patient outcomes: an effective gate- keeper for coronary angiography and revascularization. J Am Soc Echocardiogr. 2010;23:832 9. 295. Braunwald E, Domanski MJ, Fowler SE, et al. Angiotensinconverting- enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004;351:2058 68. 296. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782 8. 297. Garg R, Yusuf S. Overview of randomized trials of angioten- sinconverting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273:1450 6. 298. Kunz R, Friedrich C, Wolbers M, et al. Meta-analysis: effect of mono- therapy and combination therapy with inhibitors of the renin angioten- sin system on proteinuria in renal disease. Ann Intern Med. 2008;148: 30 48. 299. McCully RB, Roger VL, Mahoney DW, et al. Outcome after abnormal exercise echocardiography for patients with good exercise capacity: prognostic importance of the extent and severity of exercise-related left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1345 52. 300. Shaw LJ, Hendel R, Borges-Neto S, et al.


2002;39:1345 52. 300. Shaw LJ, Hendel R, Borges-Neto S, et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4728 patients. J Nucl Med. 2003;44: 134 9. 301. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investi- gators. N Engl J Med. 2000;342:145 53. 302. Weiner DA, Ryan TJ, McCabe CH, et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol. 1984;3:772 9. 303. Cole CR, Blackstone EH, Pashkow FJ, et al. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341:1351 7. 304. McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol. 1998;31:144 9. 305. Hachamovitch R, Rozanski A, Hayes SW, et al. Predicting therapeutic benefit from myocardial revascularization procedures: are mea- surements of both resting left ventricular ejection fraction and stress- induced myocardial ischemia necessary? J Nucl Cardiol. 2006;13: 768 78. 306. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic bur- den: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283 91. 307. Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329 40. 308. Chaowalit N, McCully RB, Callahan MJ, et al.


2003;41:1329 40. 308. Chaowalit N, McCully RB, Callahan MJ, et al. Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients. Eur Heart J. 2006;27:3039 44. 309. Elhendy A, Mahoney DW, Khandheria BK, et al. Prognostic signif- icance of the location of wall motion abnormalities during exercise echocardiography. J Am Coll Cardiol. 2002;40:1623 9. 310. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratifi- cation for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535 43. 311. Marwick TH, Case C, Vasey C, et al. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation. 2001;103:2566 71. 312. Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001;37:754 60. 313. Shaw LJ, Hachamovitch R, Heller GV, et al. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Eco- nomics of Noninvasive Diagnosis (END) Study Group. Am J Cardiol. 2000;86:1 7. 314. Shaw LJ, Hendel RC, Cerquiera M, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single- photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;45:1494 504. 315. Shaw LJ, Vasey C, Sawada S, et al. Impact of gender on risk stratifi- cation by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005;26:447 56. 316. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circu- lation. 1999;100:2140 5. 317. Hachamovitch R, Berman DS, Kiat H, et al.


1999;100:2140 5. 317. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93:905 14. 318. Levy D, Salomon M, D Agostino RB, et al. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90: 1786 93. 319. Poornima IG, Miller TD, Christian TF, et al. Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol. 2004;43:194 9. 320. Hachamovitch R, Hayes SW, Friedman JD, et al. A prognostic score for prediction of cardiac mortality risk after adenosine stress myo- cardial perfusion scintigraphy. J Am Coll Cardiol. 2005;45:722 9. 321. America YG, Bax JJ, Boersma E, et al. The additive prognostic value of perfusion and functional data assessed by quantitative gated SPECT in women. J Nucl Cardiol. 2009;16:10 9. 322. Sharir T, Kang X, Germano G, et al. Prognostic value of poststress left ventricular volume and ejection fraction by gated myocardial perfusion SPECT in women and men: gender-related differences in normal limits and outcomes. J Nucl Cardiol. 2006;13:495 506. 323. Yoshinaga K, Chow BJ, Williams K, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48:1029 39. 324. Yao SS, Qureshi E, Sherrid MV, et al. Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol. 2003; 42:1084 90. 325. Lertsburapa K, Ahlberg AW, Bateman TM, et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol. 2008;15: 745 53. 326.


Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol. 2008;15: 745 53. 326. Hachamovitch R. Risk assessment of patients with known or suspected CAD using stress myocardial perfusion SPECT. Part I: The ongoing evolution of clinical evidence. Rev Cardiovasc Med. 2000;1:91 102. 327. Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900 7. 328. Gehi AK, Ali S, Na B, et al. Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2008;168: 1423 8. 329. Bodi V, Sanchis J, Lopez-Lereu MP, et al. Prognostic value of dipyr- idamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2007;50:1174 9. 330. Bangalore S, Yao SS, Chaudhry FA. Usefulness of stress echocardi- ography for risk stratification and prognosis of patients with left ven- tricular hypertrophy. Am J Cardiol. 2007;100:536 43. 331. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 1999;100:1035 42. 332. Abidov A, Bax JJ, Hayes SW, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol. 2003;42:1818 25. 333. Parisi AF, Hartigan PM, Folland ED.


J Am Coll Cardiol. 2003;42:1818 25. 333. Parisi AF, Hartigan PM, Folland ED. Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease. Findings from the Angioplasty Compared to Medicine (ACME) Study. J Am Coll Cardiol. 1997;30:1256 63. 334. Poldermans D, Fioretti PM, Boersma E, et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation. 1999;99:757 62. 335. Kamalesh M, Matorin R, Sawada S. Prognostic value of a negative stress echocardiographic study in diabetic patients. Am Heart J. 2002; 143:163 8. 336. Bjork Ingul C, Rozis E, Slordahl SA, et al. Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography. Circulation. 2007;115:1252 9. 337. Poldermans D, Rambaldi R, Fioretti PM, et al. Prognostic value of dobutamine-atropine stress echocardiography for peri-operative and late cardiac events in patients scheduled for vascular surgery. Eur Heart J. 1997;18 Suppl D:D86 D96. 338. Shaw LJ, Eagle KA, Gersh BJ, et al. Meta-analysis of intravenous echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol. 1996;27:787 98. 339. Hachamovitch R, Berman DS, Kiat H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol. 1997;80:426 33. 340. Lima RS, De Lorenzo A, Pantoja MR, et al. Incremental prognostic value of myocardial perfusion 99m-technetium-sestamibi SPECT in the elderly. Int J Cardiol. 2004;93:137 43. 341. Schinkel AF, Elhendy A, Biagini E, et al. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing. J Nucl Med. 2005;46:12 8. 342.


Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing. J Nucl Med. 2005;46:12 8. 342. Rozanski A, Gransar H, Hayes SW, et al. Comparison of long-term mortality risk following normal exercise vs adenosine myocardial per- fusion SPECT. J Nucl Cardiol. 2010;17:999 1008. 343. Wallace EL, Morgan TM, Walsh TF, et al. Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. J Am Coll Cardiol Car- diovasc Imaging. 2009;2:299 307. 344. Cortigiani L, Picano E, Vigna C, et al. Prognostic value of pharma- cologic stress echocardiography in patients with left bundle branch block. Am J Med. 2001;110:361 9. 345. Min JK, Shaw LJ, Devereux RB, et al. Prognostic value of multide- tector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol. 2007;50:1161 70. 346. Small GR, Yam Y, Chen L, et al. Prognostic assessment of coronary artery bypass patients with 64-slice computed tomography angiography anatomical information is incremental to clinical risk prediction. J Am Coll Cardiol. 2011;58:2389 95. 347. Chow BJ, Ahmed O, Small G, et al. Prognostic value of CT angiography in coronary bypass patients. J Am Coll Cardiol Car- diovasc Imaging. 2011;4:496 502. 348. Hachamovitch R, Johnson JR, Hlatky MA, et al. The study of myo- cardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes. J Nucl Cardiol. 2009;16:935 48. 349. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Con- sensus statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Circulation.


Con- sensus statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Circulation. 1997;95:265 72. 350. Every NR, Fahrenbruch CE, Hallstrom AP, et al. Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol. 1992;19:1435 9. 351. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med. 1997;336:1629 33. 352. Califf RM, Harrell FE Jr, Lee KL, et al. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA. 1989;261:2077 86. 353. Myers WO, Schaff HV, Gersh BJ, et al. Improved survival of sur- gically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry. J Thorac Cardiovasc Surg. 1989;97:487 95. 354. Myers WO, Gersh BJ, Fisher LD, et al. Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg. 1987;44:471 86. 355. Bonow RO, Maurer G, Lee KL, et al. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction. N Engl J Med. 2011;364:1617 25. 356. Brunelli C, Cristofani R, L Abbate A. Long-term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1). Eur Heart J. 1989;10:292 303. 357. Chuah SC, Pellikka PA, Roger VL, et al. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation. 1998;97:1474 80. Fihn et al Stable Ischemic Heart Disease: Full Text e443 358.


Fihn et al Stable Ischemic Heart Disease: Full Text e443 358. Harris PJ, Harrell FE Jr, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259 69. 359. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464 71. 360. Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiog- raphy for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83 90. 361. Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium- 99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ische- mia: outcome with medical therapy versus revascularization. Mayo Clin Proc. 1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al. Long-term survival of med- ically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645 57. 365. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 366. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 367. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951 60. 368.


Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951 60. 368. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217 25. 369. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the inter- pretation of coronary angiograms on the appropriateness of use of coro- nary revascularization procedures. Am Heart J. 2000;139:106 13. 370. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myo- cardial infarction. J Am Coll Cardiol. 1988;12:56 62. 371. Little WC, Constantinescu M,Applegate RJ, et al. Can coronary angiogra- phy predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157 66. 372. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006;47:C101 C103. 373. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Adminis- tration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984;311:1333 9. 374. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angio- graphic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 1983;71:1854 66. 375. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629 46. 376. Gersh BJ, Califf RM, Loop FD, et al. Coronary bypass surgery in chronic stable angina. Circulation. 1989;79:I46 I59. 377. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of ther- apy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015 25. 377a. Snow V, Barry P, Fihn SD, et al.


1994;89:2015 25. 377a. Snow V, Barry P, Fihn SD, et al. Evaluation of primary care patients with chronic stable angina: guidelines from the American College of Physicians. Ann Intern Med. 2004;141:57 64. 378. Califf RM, Phillips HR, III, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055 63. 379. Nakagomi A, Celermajer DS, Lumley T, et al. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol. 1996;78:516 9. 380. Campeau L, Corbara F, Crochet D, et al. Left main coronary artery stenosis: the influence of aortocoronary bypass surgery on survival. Circulation. 1978;57:1111 5. 381. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery dis- ease. Long-term CASS experience. Circulation. 1995;91:2325 34. 382. Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947 52. 383. Cameron A, Kemp HG Jr, Fisher LD, et al. Left main coronary artery stenosis: angiographic determination. Circulation. 1983;68:484 9. 358. Harris PJ, Harrell FE Jr, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259 69. 359. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464 71. 360. Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiog- raphy for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83 90. 361. Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362.


Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium- 99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ische- mia: outcome with medical therapy versus revascularization. Mayo Clin Proc. 1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al. Long-term survival of med- ically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645 57. 365. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 366. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 367. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951 60. 368. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217 25. 369. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J. 2000;139:106 13. 370. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myo- cardial infarction. J Am Coll Cardiol. 1988;12:56 62. 371. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?


Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157 66. 372. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006;47:C101 C103. 373. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Adminis- tration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984;311:1333 9. 374. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angio- graphic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 1983;71:1854 66. 375. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629 46. 376. Gersh BJ, Califf RM, Loop FD, et al. Coronary bypass surgery in chronic stable angina. Circulation. 1989;79:I46 I59. 377. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015 25. 378. Califf RM, Phillips HR, III, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055 63. 379. Nakagomi A, Celermajer DS, Lumley T, et al. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol. 1996;78:516 9. 380. Campeau L, Corbara F, Crochet D, et al. Left main coronary artery stenosis: the influence of aortocoronary bypass surgery on survival. Circulation. 1978;57:1111 5. 381. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2325 34. 382. Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation.


Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947 52. 383. Cameron A, Kemp HG Jr, Fisher LD, et al. Left main coronary artery stenosis: angiographic determination. Circulation. 1983;68:484 9. 384. Isner JM, Kishel J, Kent KM, et al. Accuracy of angiographic deter- mination of left main coronary arterial narrowing. Angiographic histologic correlative analysis in 28 patients. Circulation. 1981;63: 1056 64. 385. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ische- mic heart disease. Circulation. 1995;92:2333 42. 386. West JN, Bennett MR, Pentecost BL. Association of transient abnormal Q-waves during exercise testing with a stenosis of the main stem of the left coronary artery. Int J Cardiol. 1991;31:102 4. 387. Gibbons RJ, Fyke FE, III, Brown ML, et al. Comparison of exercise performance in left main and three-vessel coronary artery disease. Cathet Cardiovasc Diagn. 1991;22:14 20. 388. Janosi A, Vertes A. Exercise testing and left main coronary artery stenosis. Can patients with left main disease be identified? Chest. 1991;100:227 9. 389. Morris SN, Phillips JF, Jordan JW, et al. Incidence and significance of decreases in systolic blood pressure during graded treadmill exercise testing. Am J Cardiol. 1978;41:221 6. 390. Plotnick GD, Greene HL, Carliner NH, et al. Clinical indicators of left main coronary artery disease in unstable angina. Ann Intern Med. 1979;91:149 53. 391. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980 2000. N Engl J Med. 2007;356: 2388 98. 392. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937 52. 393. Bhatt DL, Fox KA, Hacke W, et al.


2004;364:937 52. 393. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706 17. 394. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383 9. 395. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investi- gators. N Engl J Med. 1996;335:1001 9. 396. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cho- lesterol levels. The Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349 57. 397. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorva- statin versus Revascularization Treatment Investigators. N Engl J Med. 1999;341:70 6. 398. MRC-BHF Heart Protection Study of cholesterol lowering with sim- vastatin in 20,536 high-risk individuals: a randomised placebocon- trolled trial. Lancet. 2002;360:7 22. 399. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20 8. 400. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425 35. 401. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med. 2004; 164:1427 36. 402. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489 97. 403. Hebert PR, Moser M, Mayer J, et al.


1998;339:489 97. 403. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578 81. 404. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002;8:1257 62. 405. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461 8. 406. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation. 2004;110:1213 8. 407. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359: 677 87. at AHA National Center on February 11, 2014 http://circ.ahajournals.org/ Downloaded from 358. Harris PJ, Harrell FE Jr, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259 69. 359. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464 71. 360. Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiog- raphy for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83 90. 361. Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium- 99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al.


1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ische- mia: outcome with medical therapy versus revascularization. Mayo Clin Proc. 1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al. Long-term survival of med- ically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645 57. 365. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 366. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 367. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951 60. 368. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217 25. 369. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J. 2000;139:106 13. 370. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myo- cardial infarction. J Am Coll Cardiol. 1988;12:56 62. 371. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157 66. 372. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006;47:C101 C103. 373. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.


Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Adminis- tration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984;311:1333 9. 374. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angio- graphic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 1983;71:1854 66. 375. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629 46. 376. Gersh BJ, Califf RM, Loop FD, et al. Coronary bypass surgery in chronic stable angina. Circulation. 1989;79:I46 I59. 377. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015 25. 378. Califf RM, Phillips HR, III, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055 63. 379. Nakagomi A, Celermajer DS, Lumley T, et al. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol. 1996;78:516 9. 380. Campeau L, Corbara F, Crochet D, et al. Left main coronary artery stenosis: the influence of aortocoronary bypass surgery on survival. Circulation. 1978;57:1111 5. 381. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2325 34. 382. Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947 52. 383. Cameron A, Kemp HG Jr, Fisher LD, et al. Left main coronary artery stenosis: angiographic determination. Circulation. 1983;68:484 9. 384. Isner JM, Kishel J, Kent KM, et al.


1983;68:484 9. 384. Isner JM, Kishel J, Kent KM, et al. Accuracy of angiographic deter- mination of left main coronary arterial narrowing. Angiographic histologic correlative analysis in 28 patients. Circulation. 1981;63: 1056 64. 385. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ische- mic heart disease. Circulation. 1995;92:2333 42. 386. West JN, Bennett MR, Pentecost BL. Association of transient abnormal Q-waves during exercise testing with a stenosis of the main stem of the left coronary artery. Int J Cardiol. 1991;31:102 4. 387. Gibbons RJ, Fyke FE, III, Brown ML, et al. Comparison of exercise performance in left main and three-vessel coronary artery disease. Cathet Cardiovasc Diagn. 1991;22:14 20. 388. Janosi A, Vertes A. Exercise testing and left main coronary artery stenosis. Can patients with left main disease be identified? Chest. 1991;100:227 9. 389. Morris SN, Phillips JF, Jordan JW, et al. Incidence and significance of decreases in systolic blood pressure during graded treadmill exercise testing. Am J Cardiol. 1978;41:221 6. 390. Plotnick GD, Greene HL, Carliner NH, et al. Clinical indicators of left main coronary artery disease in unstable angina. Ann Intern Med. 1979;91:149 53. 391. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980 2000. N Engl J Med. 2007;356: 2388 98. 392. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937 52. 393. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706 17. 394. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383 9.


Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383 9. 395. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investi- gators. N Engl J Med. 1996;335:1001 9. 396. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cho- lesterol levels. The Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349 57. 397. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorva- statin versus Revascularization Treatment Investigators. N Engl J Med. 1999;341:70 6. 398. MRC-BHF Heart Protection Study of cholesterol lowering with sim- vastatin in 20,536 high-risk individuals: a randomised placebocon- trolled trial. Lancet. 2002;360:7 22. 399. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20 8. 400. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425 35. 401. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med. 2004; 164:1427 36. 402. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489 97. 403. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578 81. 404. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.


Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002;8:1257 62. 405. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461 8. 406. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation. 2004;110:1213 8. 407. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359: 677 87. at AHA National Center on February 11, 2014 http://circ.ahajournals.org/ Downloaded from 358. Harris PJ, Harrell FE Jr, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259 69. 359. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464 71. 360. Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiog- raphy for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83 90. 361. Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium- 99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ische- mia: outcome with medical therapy versus revascularization. Mayo Clin Proc. 1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al.


1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al. Long-term survival of med- ically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645 57. 365. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 366. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 367. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951 60. 368. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217 25. 369. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J. 2000;139:106 13. 370. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myo- cardial infarction. J Am Coll Cardiol. 1988;12:56 62. 371. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157 66. 372. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006;47:C101 C103. 373. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Adminis- tration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984;311:1333 9. 374. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angio- graphic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS).


Prognostic value of angio- graphic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 1983;71:1854 66. 375. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629 46. 376. Gersh BJ, Califf RM, Loop FD, et al. Coronary bypass surgery in chronic stable angina. Circulation. 1989;79:I46 I59. 377. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015 25. 378. Califf RM, Phillips HR, III, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055 63. 379. Nakagomi A, Celermajer DS, Lumley T, et al. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol. 1996;78:516 9. 380. Campeau L, Corbara F, Crochet D, et al. Left main coronary artery stenosis: the influence of aortocoronary bypass surgery on survival. Circulation. 1978;57:1111 5. 381. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2325 34. 382. Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947 52. 383. Cameron A, Kemp HG Jr, Fisher LD, et al. Left main coronary artery stenosis: angiographic determination. Circulation. 1983;68:484 9. 384. Isner JM, Kishel J, Kent KM, et al. Accuracy of angiographic deter- mination of left main coronary arterial narrowing. Angiographic histologic correlative analysis in 28 patients. Circulation. 1981;63: 1056 64. 385. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ische- mic heart disease. Circulation. 1995;92:2333 42. 386.


The dissociation between clinical and angiographic findings in ische- mic heart disease. Circulation. 1995;92:2333 42. 386. West JN, Bennett MR, Pentecost BL. Association of transient abnormal Q-waves during exercise testing with a stenosis of the main stem of the left coronary artery. Int J Cardiol. 1991;31:102 4. 387. Gibbons RJ, Fyke FE, III, Brown ML, et al. Comparison of exercise performance in left main and three-vessel coronary artery disease. Cathet Cardiovasc Diagn. 1991;22:14 20. 388. Janosi A, Vertes A. Exercise testing and left main coronary artery stenosis. Can patients with left main disease be identified? Chest. 1991;100:227 9. 389. Morris SN, Phillips JF, Jordan JW, et al. Incidence and significance of decreases in systolic blood pressure during graded treadmill exercise testing. Am J Cardiol. 1978;41:221 6. 390. Plotnick GD, Greene HL, Carliner NH, et al. Clinical indicators of left main coronary artery disease in unstable angina. Ann Intern Med. 1979;91:149 53. 391. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980 2000. N Engl J Med. 2007;356: 2388 98. 392. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937 52. 393. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706 17. 394. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383 9. 395. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investi- gators. N Engl J Med. 1996;335:1001 9. 396.


Cholesterol and Recurrent Events Trial investi- gators. N Engl J Med. 1996;335:1001 9. 396. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cho- lesterol levels. The Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349 57. 397. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorva- statin versus Revascularization Treatment Investigators. N Engl J Med. 1999;341:70 6. 398. MRC-BHF Heart Protection Study of cholesterol lowering with sim- vastatin in 20,536 high-risk individuals: a randomised placebocon- trolled trial. Lancet. 2002;360:7 22. 399. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20 8. 400. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425 35. 401. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med. 2004; 164:1427 36. 402. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489 97. 403. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578 81. 404. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002;8:1257 62. 405. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461 8. 406.


Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461 8. 406. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation. 2004;110:1213 8. 407. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359: 677 87. 408. Frye RL, August P, Brooks MM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009; 360:2503 15. 409. Chaitman BR, Hardison RM, Adler D, et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of dif- ferent treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mor- tality and myocardial infarction. Circulation. 2009;120:2529 40. 410. Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364: 1607 16. 411. Pittman MA, Margolin FS. Community health. Crossing the quality chasm: steps you can take. Trustee. 2001;54:30 2. 412. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collabo- ration. Lancet. 1994;344:563 70. 413. Nikolsky E, Gruberg L, Patil CV, et al. Percutaneous coronary inter- ventions in diabetic patients: is complete revascularization important? J Invasive Cardiol. 2004;16:102 6. 414. Osswald BR, Tochtermann U, Schweiger P, et al. Does the com- pleteness of revascularization contribute to an improved early survival in patients up to 70 years of age?


Does the com- pleteness of revascularization contribute to an improved early survival in patients up to 70 years of age? Thorac Cardiovasc Surg. 2001;49: 373 7. 415. Kleisli T, Cheng W, Jacobs MJ, et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2005;129:1283 91. 416. Kozower BD, Moon MR, Barner HB, et al. Impact of complete revas- cularization on long-term survival after coronary artery bypass grafting in octogenarians. Ann Thorac Surg. 2005;80:112 6. 417. McLellan CS, Ghali WA, Labinaz M, et al. Association between completeness of percutaneous coronary revascularization and postpro- cedure outcomes. Am Heart J. 2005;150:800 6. 418. Wenaweser P, Surmely JF, Windecker S, et al. Prognostic value of early exercise testing after coronary stent implantation. Am J Cardiol. 2008;101:807 11. 419. Martuscelli E, Clementi F, Gallagher MM, et al. Revascularization strategy in patients with multivessel disease and a major vessel chron- ically occluded; data from the CABRI trial. Eur J Cardiothorac Surg. 2008;33:4 8. 420. Heidenreich PA, McDonald KM, Hastie T, et al. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA. 1999;281:1927 36. 421. Moss AJ, Zareba W, Schwarz KQ, et al. Ranolazine shortens repolar- ization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol. 2008;19:1289 93. 422. Holmes DR Jr, Gersh BJ, Whitlow P, et al. Percutaneous coronary intervention for chronic stable angina: a reassessment. J Am Coll Cardiol Intv. 2008;1:34 43. 423. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA. 2011;306:53 61. 424. Poses RM, Krueger JI, Sloman S, et al. Physicians judgments of survival after medical management and mortality risk reduction due to revascularization procedures for patients with coronary artery disease. Chest. 2002;122:122 33. 425.


Physicians judgments of survival after medical management and mortality risk reduction due to revascularization procedures for patients with coronary artery disease. Chest. 2002;122:122 33. 425. Holmboe ES, Fiellin DA, Cusanelli E, et al. Perceptions of benefit and risk of patients undergoing first-time elective percutaneous coronary revascularization. J Gen Intern Med. 2000;15:632 7. 426. Lin GA, Dudley RA, Redberg RF. Cardiologists use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007;167:1604 9. 427. Ko DT, Wang Y, Alter DA, et al. Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction. J Am Coll Cardiol. 2008;51:716 23. 428. Fisher E, Goodman D, Skinner J, et al. Health care spending, quality, and outcomes: more isn t always better: a topic brief by the Dartmouth AtlasofHealthCareProject.http://www.dartmouthatlas.org/downloads/ reports/Spending_Brief_022709.pdf. 2009. Accessed January 6, 2012. 429. Charatan F. Dozens of patients allege unnecessary heart surgery. BMJ. 2003;326:1055. 430. Fred HL. Dishonesty in medicine revisited. Tex Heart Inst J. 2008; 35:6 15. 431. Nallamothu BK, Rogers MA, Chernew ME, et al. Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries. JAMA. 2007;297:962 8. 432. Campeau L. Letter: Grading of angina pectoris. Circulation. 1976;54: 522 3. 433. The Criteria Committee of the New York Heart Association I. Diseases of the heart and blood vessels: nomenclature and critera for diagnosis. 6th ed. Boston: Little, Brown; 1964. 434. Spertus JA, Eagle KA, Krumholz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005;45:1147 56. 435. Spertus JA, Winder JA, Dewhurst TA, et al. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol. 1994;74: 1240 4. 436.


Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol. 1994;74: 1240 4. 436. Drozda J Jr, Messer JV, Spertus J, et al. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foun- dation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Con- sortium for Performance Improvement. Circulation. 2011;124: 248 70. 437. McGillion M, Watt-Watson J, LeFort S, et al. Positive shifts in the perceived meaning of cardiac pain following a psychoeducation program for chronic stable angina. Can J Nurs Res. 2007;39:48 65. 438. Muszbek N, Brixner D, Benedict A, et al. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. Int J Clin Pract. 2008;62:338 51. 439. Rao SV, Schulman KA, Curtis LH, et al. Socioeconomic status and outcome following acute myocardial infarction in elderly patients. Arch Intern Med. 2004;164:1128 33. 440. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women 2011 update: a guideline from the American Heart Association. Circulation. 2011; 123:1243 62. 441. Joint Commission. The Joint Commission announces the 2008 National Patient Safety Goals and Requirements. Jt Comm Perspect. 2007;27: 1,9 1,22. 442. Miller NH, Taylor C. Lifestyle Management for Patients with Coronary Heart Disease. (Current Issues in Cardiac Rehabilitation, Monograph No. 2.). 1st ed. Champaign, IL: Human Kinetics; 1995. 443. DeBusk RF, Miller NH, Superko HR, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med. 1994;120:721 9. 444. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease.


Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994;89: 975 90. 445. Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recom- mendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82 96. 446. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovas- cular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcom- mittee on Physical Activity). Circulation. 2003;107:3109 16. 447. Thompson PD, Franklin BA, Balady GJ, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Car- diology. Circulation. 2007;115:2358 68. 448. Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovas- cular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:406 41. 449. National Institutes of Health, National Heart Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. http:// www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. 1998. Accessed January 6, 2012. 450. Oka R, Kobayashi J, Yagi K, et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract. 2008;79:474 81. Fihn et al Stable Ischemic Heart Disease: Full Text e445 451. Tan CE, Ma S, Wai D, et al.


Fihn et al Stable Ischemic Heart Disease: Full Text e445 451. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182 6. 452. Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of car- diovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115:114 26. 453. Bosworth HB, Olsen MK, Dudley T, et al. The Take Control of Your Blood pressure (TCYB) study: study design and methodology. Contemp Clin Trials. 2007;28:33 47. 454. The 2004 United States Surgeon General s Report: The Health Con- sequences of Smoking. N S W Public Health Bull. 2004;15:107. 455. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86 97. 456. Standards of medical care in diabetes 2011. Diabetes Care. 2011;34 Suppl 1:S11 S61. 457. Appel LJ, Champagne CM, Harsha DW, et al. Effects of compre- hensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083 93. 458. Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 1670 81. 459. Frattaroli J, Weidner G, Merritt-Worden TA, et al. Angina pectoris and atherosclerotic risk factors in the multisite cardiac lifestyle intervention program. Am J Cardiol. 2008;101:911 8. 460. Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88 90. 461. Rees K, Bennett P, West R, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev. 2004;CD002902. 462. Ziegelstein RC, Fauerbach JA, Stevens SS, et al.


2004;CD002902. 462. Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818 23. 463. Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of cita- lopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297:367 79. 464. McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol. 2005;96:1076 81. 465. Deleted in proof. 466. Deleted in proof. 467. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA. 2006;295:2874 81. 468. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and Coronary Heart Disease. Recommendations for Screening, Referral, and Treatment. A Science Advisory From the American Heart Asso- ciation Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2008;118:1768 75. 469. Patient education. American Academy of Family Physicians. Am Fam Physician. 2000;62:1712 4. 470. Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update. Rockville (MD): US Department of Health and Human Services. 2008. Available at: http://www.ncbi.nlm. 2012. 471. Smith PM, Taylor CB. Implementing an Inpatient Smoking Cessation Program. Lawrence Erlbaum Associates, Inc.: 2006. 472. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343 50. 473. Kok G, van den Borne B, Mullen PD. Effectiveness of health education and health promotion: meta-analyses of effect studies and determinants of effectiveness. Patient Educ Couns. 1997;30:19 27. 474.


Effectiveness of health education and health promotion: meta-analyses of effect studies and determinants of effectiveness. Patient Educ Couns. 1997;30:19 27. 474. Glynn LG, Murphy AW, Smith SM, et al. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010;3:CD005182. 475. American Heart Association. AHA Choose to Move. American Heart Association. 2008. Available at: http://www.choosetomove.org. Accessed June 24, 2008. 476. Miller W, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed. New York: Guilford; 2002. 477. Bandura A, Cervone D. Self-evaluative and self-efficacy mechanisms governing the motivational effects of goal systems. J Pers Soc Psych. 1983;45:1017 28. 478. Prochaska J, Norcross J, DiClemente C. Changing for Good: A Rev- olutionary Six Stage Program for Overcoming Bad Habits and Moving Your Life Positively Forward. New York: Avon Books, Inc.; 1984. 479. Coleman K, Austin BT, Brach C, et al. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood). 2009;28:75 85. 480. Dorr DA, Wilcox AB, Brunker CP, et al. The effect of technologysup- ported, multidisease care management on the mortality and hospital- ization of seniors. J Am Geriatr Soc. 2008;56:2195 202. 481. Reid RJ, Fishman PA, Yu O, et al. Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care. 2009;15:e71 e87. 482. Bohlen JG, Held JP, Sanderson MO, et al. Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch Intern Med. 1984;144:1745 8. 483. Moller J, Ahlbom A, Hulting J, et al. Sexual activity as a trigger of myocardial infarction. A case-crossover analysis in the Stockholm Heart Epidemiology Programme (SHEEP). Heart. 2001;86:387 90. 484. Muller JE. Triggering of cardiac events by sexual activity: findings from a case-crossover analysis. Am J Cardiol. 2000;86:14F 8F. 485.


Triggering of cardiac events by sexual activity: findings from a case-crossover analysis. Am J Cardiol. 2000;86:14F 8F. 485. Ebrahim S, May M, Ben Shlomo Y, et al. Sexual intercourse and risk of ischaemic stroke and coronary heart disease: the Caerphilly study. J Epidemiol Community Health. 2002;56:99 102. 486. Dahabreh IJ, Paulus JK. Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis. JAMA. 2011;305:1225 33. 487. Cheitlin MD. Sexual activity and cardiac risk. Am J Cardiol. 2005;96: 24M 8M. 488. Grimm RH Jr, Grandits GA, Prineas RJ, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hyper- tension Study (TOMHS). Hypertension. 1997;29:8 14. 489. Dusing R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs. 2005;65:773 86. 490. Franzen D, Metha A, Seifert N, et al. Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, ran- domized and double blinded study. Int J Impot Res. 2001;13:348 51. 491. Baumhakel M, Schlimmer N, Kratz M, et al. Cardiovascular risk, drugs and erectile function a systematic analysis. Int J Clin Pract. 2011;65: 289 98. 492. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351 7. 493. Padma-nathan H, Eardley I, Kloner RA, et al. A 4-year update on the safety of sildenafil citrate (Viagra). Urology. 2002;60:67 90. 494. Montorsi F, Verheyden B, Meuleman E, et al. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol. 2004;45:339 44. 495. Kloner RA, Jackson G, Emmick JT, et al. Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, dox- azosin and tamsulosin in healthy normotensive men. J Urol.


Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, dox- azosin and tamsulosin in healthy normotensive men. J Urol. 2004; 172:1935 40. 496. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56: 320 8. 497. Ginsberg HN, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol. 1998;18:441 9. 498. Schaefer EJ, Lamon-Fava S, Ausman LM, et al. Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr. 1997;65:823 30. 499. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, et al. Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol. 1995;15:1079 85. 500. Yu-Poth S, Zhao G, Etherton T, et al. Effects of the National Choles- terol Education Program s Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a metaanalysis. Am J Clin Nutr. 1999;69:632 46. 501. Pedersen TR, Faergeman O, Kastelein JJ, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005;294:2437 45. 502. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984;251: 351 64. 503. Deleted in proof. 504. Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986;8:1245 55. 505. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, anti- oxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583 92. 506.


Simvastatin and niacin, anti- oxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583 92. 506. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365 74. 507. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256: 2823 8. 508. Wilson PW, D Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97: 1837 47. 509. Pekkanen J, Linn S, Heiss G, et al. Ten-year mortality from cardio- vascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med. 1990;322: 1700 7. 510. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med. 1990;323:1112 9. 511. Wong ND, Wilson PW, Kannel WB. Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study. Ann Intern Med. 1991;115:687 93. 512. Chen JT, Wesley R, Shamburek RD, et al. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus poli- cosanol. Pharmacotherapy. 2005;25:171 83. 513. Goldberg AC Ostlund RE Jr, Bateman JH, et al. Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs. Am J Cardiol. 2006;97:376 9. 514. Hallikainen MA, Sarkkinen ES, Uusitupa MI. Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr. 2000;130:767 76. 515. Nguyen TT, Dale LC, von Bergmann K, et al.


515. Nguyen TT, Dale LC, von Bergmann K, et al. Cholesterollowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial. Mayo Clin Proc. 1999;74:1198 206. 516. Durstine JL, Grandjean PW, Cox CA, et al. Lipids, lipoproteins, and exercise. J Cardiopulm Rehabil. 2002;22:385 98. 517. Durstine JL, Grandjean PW, Davis PG, et al. Blood lipid and lipo- protein adaptations to exercise: a quantitative analysis. Sports Med. 2001;31:1033 62. 518. Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc. 2001;33:S502 15. 519. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002;288:2998 3007. 520. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495 504. 521. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149 58. 522. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623 30. 523. Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161:1413 9. 524. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high- density lipoprotein cholesterol. Veterans Affairs High-Density Lipo- protein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341:410 8. 525.


Veterans Affairs High-Density Lipo- protein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341:410 8. 525. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289 98. 526. Whelton SP, He J, Whelton PK, et al. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol. 2004;93:1119 23. 527. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell Infarto miocardico. Lancet. 1999;354:447 55. 528. Durrington PN, Bhatnagar D, Mackness MI, et al. An omega-3 poly- unsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart. 2001;85:544 8. 529. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high- normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med. 1997;157:657 67. 530. Stevens VJ, Corrigan SA, Obarzanek E, et al. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Col- laborative Research Group. Arch Intern Med. 1993;153:849 58. 531. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a ran- domized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998; 279:839 46. 532. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117 24. 533.


DASH Collaborative Research Group. N Engl J Med. 1997;336:1117 24. 533. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hyper- tension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3 10. 534. MacGregor GA, Markandu ND, Sagnella GA, et al. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;2:1244 7. 535. Whelton SP, Chin A, Xin X, et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136:493 503. 536. Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hyper- tension. 2001;38:1112 7. 537. Appel LJ, Frohlich ED, Hall JE, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascu- lar disease and stroke: a call to action from the American Heart Association. Circulation. 2011;123:1138 43. 538. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ. 1992;304:405 12. 539. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255 64. 540. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed). 1985;291: 97 104. 541. Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-year findings of the hypertension detection and follow-up program. Hypertension. 1984;6:I198 I206. 542. The effect of treatment on mortality in mild hypertension: results of the hypertension detection and follow-up program. N Engl J Med. 1982;307:976 80. 543.


The effect of treatment on mortality in mild hypertension: results of the hypertension detection and follow-up program. N Engl J Med. 1982;307:976 80. 543. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979;242:2562 71. Fihn et al Stable Ischemic Heart Disease: Full Text e447 544. Major outcomes in high-risk hypertensive patients randomized to an- giotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981 97. 545. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527 35. 546. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of indi- vidual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903 13. 547. Collins R, Peto R. Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Swales JD, editor. Textbook of Hyper- tension. Blackwell Scientific Publications; 1994. 548. Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hyper- tension. 2003;42:878 84. 549. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Pre- vention, phase II. Ann Intern Med. 2001;134:1 11. 550. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761 70. 551. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887 98. 552.